Relationship between the VEGF mRNA expression and clinicopathologic features in ovarian carcinoma
| VEGF (+) | VEGF expression | |||
|---|---|---|---|---|
| Characteristics | n (%) | P | x ± s | P |
| Age, years | ||||
| ≥ 51 | 24/24 (100) | 1.000 | 0.82 ± 0.25 | 0.121 |
| < 51 | 27/27 (100) | 0.71 ± 0.27 | ||
| Histological type | ||||
| Serous carcinoma | 39/39 (100) | 1.000 | 0.77 ± 0.25 | 0.446 |
| Others | 12/12 (100) | 0.86 ± 0.32 | ||
| Differentiation | ||||
| Moderately/Well differentiated | 11/11 (100) | 1.000 | 0.77 ± 0.34 | 0.762 |
| Poor differentiated | 40/40 (100) | 0.80 ± 0.24 | ||
| Clinical stage | ||||
| I-II | 18/18 (100) | 1.000 | 0.60 ± 0.21 | 0.000 |
| III-IV | 33/33 (100) | 0.94 ± 0.22 | ||
| Lymph node metastasis | ||||
| No | 32/32 (100) | 1.000 | 0.74 ± 0.27 | 0.031 |
| Yes | 19/19 (100) | 1.00 ± 0.15 | ||